NO20022532L - Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser - Google Patents

Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser

Info

Publication number
NO20022532L
NO20022532L NO20022532A NO20022532A NO20022532L NO 20022532 L NO20022532 L NO 20022532L NO 20022532 A NO20022532 A NO 20022532A NO 20022532 A NO20022532 A NO 20022532A NO 20022532 L NO20022532 L NO 20022532L
Authority
NO
Norway
Prior art keywords
nucleic acids
synthesis
preparation
new compounds
environmental test
Prior art date
Application number
NO20022532A
Other languages
English (en)
Other versions
NO20022532D0 (no
Inventor
Pascale Jeannin
Jean-Luc Pernodet
Michel Guerineau
Pascal Simonet
Sophie Courtois
Cormela Cappellano
Francois Francou
Alain Raynal
Maria Ball
Guennadi Sezonov
Karine Tuphile
Aasa Frostegaard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9915032A external-priority patent/FR2801609B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20022532D0 publication Critical patent/NO20022532D0/no
Publication of NO20022532L publication Critical patent/NO20022532L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20022532A 1999-11-29 2002-05-28 Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser NO20022532L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9915032A FR2801609B1 (fr) 1999-11-29 1999-11-29 Procede d'obtention d'acides nucleiques a partir d'un echantillon de l'environnement, acides nucleiques ainsi obtenus et leur application a la synthese de nouveaux composes
US20980000P 2000-06-07 2000-06-07
PCT/FR2000/003311 WO2001040497A2 (fr) 1999-11-29 2000-11-27 Procede d'obtention d'acides nucleiques a partir d'un echantillon de l'environnement

Publications (2)

Publication Number Publication Date
NO20022532D0 NO20022532D0 (no) 2002-05-28
NO20022532L true NO20022532L (no) 2002-06-26

Family

ID=26235170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022532A NO20022532L (no) 1999-11-29 2002-05-28 Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser

Country Status (9)

Country Link
EP (1) EP1268764A2 (no)
JP (1) JP2003520578A (no)
KR (1) KR20020060242A (no)
AU (2) AU781961B2 (no)
BR (1) BR0015993A (no)
CA (1) CA2393041A1 (no)
IL (1) IL149846A0 (no)
NO (1) NO20022532L (no)
WO (1) WO2001040497A2 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010047029A1 (en) * 2000-04-26 2001-11-29 Handelsman Jo E. Triaryl cation antibiotics from environmental DNA
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20040121309A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
WO2004060278A2 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
FR2834997B1 (fr) * 2002-01-21 2004-03-19 Evialis Procede de detection de champignons producteurs d'ochratoxine a ou de citrinine
EP1386966A1 (en) * 2002-07-24 2004-02-04 Libragen Method for the expression of unknown environmental DNA into adapted host cells
CA2495797C (en) 2002-08-20 2013-12-17 B.R.A.I.N. Biotechnology Research And Information Network Ag Isolation and cloning of dna from uncultivated organisms
EP1905833B1 (fr) 2002-10-08 2015-08-12 Aventis Pharma S.A. Polypeptides impliqués dans la biosynthèse des spiramycines, séquences nucléotidiques codant ces polypeptides et leurs applications
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
WO2005073377A1 (ja) * 2004-01-28 2005-08-11 Toudai Tlo, Ltd. 環境サンプルからのｄｎａの回収方法
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
ES2641832T3 (es) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
EP1767621A4 (en) * 2004-06-08 2008-03-19 Toagosei Co Ltd METHOD FOR PURIFYING ENVIRONMENTAL DNA AND METHOD FOR EFFECTIVELY DETECTING GENE ENCODING PROTEIN BELONGING TO ENVIRONMENTAL DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
US20060205040A1 (en) 2005-03-03 2006-09-14 Rangarajan Sampath Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
JP2009502137A (ja) 2005-07-21 2009-01-29 アイシス ファーマシューティカルズ インコーポレイティッド 核酸変種の迅速な同定および定量のための方法
US9149473B2 (en) 2006-09-14 2015-10-06 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
EP2126132B1 (en) 2007-02-23 2013-03-20 Ibis Biosciences, Inc. Methods for rapid foresnsic dna analysis
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
US8148163B2 (en) 2008-09-16 2012-04-03 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
WO2010033625A1 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Microplate handling systems and related computer program products and methods
US9175353B2 (en) 2008-11-14 2015-11-03 Gen-Probe Incorporated Compositions, kits and methods for detection of campylobacter nucleic acid
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc IONIZATION PROBE ASSEMBLIES
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
EP2454000A4 (en) 2009-07-17 2016-08-10 Ibis Biosciences Inc SYSTEMS FOR IDENTIFYING BIOLOGICAL SUBSTANCES
EP2488656B1 (en) 2009-10-15 2015-06-03 Ibis Biosciences, Inc. Multiple displacement amplification
EP2325312A1 (de) * 2009-11-19 2011-05-25 Qiagen GmbH Verfahren zur selektiven Anreicherung und Isolierung mikrobieller und optional zusätzlich viraler Nukleinsäuren
JP7709278B2 (ja) * 2020-12-28 2025-07-16 五洋建設株式会社 土砂利用の評価方法および土砂の利用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900677A (en) * 1986-09-26 1990-02-13 E. I. Du Pont De Nemours And Company Process for rapid isolation of high molecular weight DNA
CA2219136A1 (en) * 1995-04-24 1996-10-31 Chromaxome Corp. Methods for generating and screening novel metabolic pathways
US6261842B1 (en) * 1997-10-23 2001-07-17 Wisconsin Alumni Research Foundation Microorganism genomics, compositions and methods related thereto
WO1999067374A1 (en) * 1998-06-23 1999-12-29 Biosearch Italia S.P.A. Methods for transferring the capability to produce a natural product into a suitable production host

Also Published As

Publication number Publication date
NO20022532D0 (no) 2002-05-28
WO2001040497A2 (fr) 2001-06-07
AU781961B2 (en) 2005-06-23
CA2393041A1 (fr) 2001-06-07
BR0015993A (pt) 2002-08-06
AU2005211587A1 (en) 2005-10-13
IL149846A0 (en) 2002-11-10
WO2001040497A3 (fr) 2002-10-17
KR20020060242A (ko) 2002-07-16
EP1268764A2 (fr) 2003-01-02
JP2003520578A (ja) 2003-07-08
AU2179101A (en) 2001-06-12

Similar Documents

Publication Publication Date Title
NO20022532D0 (no) Fremgangsmåte for fremstilling av nukleinsyrer fra en miljöpröve, de således oppnådde nukleinsyrer samt deres anvendelseved syntese av nye forbindelser
DK1305281T3 (da) Substituerede sulfonylaminomethylbenzoesyre(derivater) samt fremgangsmåde til deres fremstilling
DE60035029D1 (de) Verfahren zur herstellung von furfural
DE69635744D1 (de) Modifizierte Nukleinsäuresonden
DE10084445T1 (de) Vorrichtung zur Herstellung von Kapseln
FR2802647B1 (fr) Sonde pour aeronef
NO20014957D0 (no) Fremgangsmåte for fremstilling av aminplatinakomplekser
ID22863A (id) Metoda untuk memproduksi bahan asam nukleat
DE69914233D1 (de) Fahrzeug-Radargerät zum korrekten Entdecken von Gegenständen
DE69920395D1 (de) Vorrichtung zur Ortsbestimmung von endokardialen Elektroden
DE60028665D1 (de) Vorrichtung zur Herstellung von Mikroarrays
NO20003965D0 (no) Nye dihydroksyheksansyre-derivater
DE50101833D1 (de) Verfahren zur Feiunverteilung von Pigmenten
DE50012558D1 (de) Verfahren zur Herstellung von Pigmentgranulaten
DE59900703D1 (de) Verfahren zur Herstellung von Chinacridonpigmenten
NO20024058L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO993912D0 (no) Fremgangsmåte for fremstilling av eprosartan
DE60042518D1 (de) Verfahren zur speicherprüfung
NO20000933D0 (no) Fremgangsmåte for fremstilling av polymer
DE69921587D1 (de) Verfahren zur Herstellung von hochchromatischen Perylenpigmenten
NO993913L (no) FremgangsmÕte for fremstilling av eprosartan
DE60119458D1 (de) Vorrichtung zur Feststellung der genetischen Sequenz von Biopolymeren
DE69913635D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
NO20014077L (no) Fremgangsmåte for krystallisering av N-(4-trifluormetylfenyl)- 5-metyl-isoksazol-4-karboksamid
NO20022956D0 (no) Fremgangsmåte for fremstilling av nitroguanidin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application